StockWatch
·

Valiant Laboratories Ltd Q4 FY25 Results

VALIANTLABQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue57.7964.0%
Total Income55.4750.7%
Expenditure54.5355.0%
PBT0.9442.0%
Net Profit0.7070.0%
OPM6.62%8.16pp
NPM1.27%5.10pp
EPS0.1670.4%
View full financials

Informational and educational content only. Not investment advice.